KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Rate: 2016-2025

Historic Tax Rate for Halozyme Therapeutics (HALO) over the last 5 years, with Sep 2025 value amounting to 19.97%.

  • Halozyme Therapeutics' Tax Rate rose 294.00% to 19.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.17%, marking a year-over-year increase of 192.00%. This contributed to the annual value of 20.29% for FY2024, which is 113.00% up from last year.
  • Halozyme Therapeutics' Tax Rate amounted to 19.97% in Q3 2025, which was up 2.85% from 19.42% recorded in Q2 2025.
  • Halozyme Therapeutics' Tax Rate's 5-year high stood at 24.41% during Q2 2022, with a 5-year trough of 0.06% in Q2 2021.
  • For the 3-year period, Halozyme Therapeutics' Tax Rate averaged around 19.76%, with its median value being 19.75% (2023).
  • In the last 5 years, Halozyme Therapeutics' Tax Rate soared by 2,435bps in 2022 and then crashed by 466bps in 2023.
  • Quarterly analysis of 5 years shows Halozyme Therapeutics' Tax Rate stood at 0.06% in 2021, then soared by 2,435bps to 18.49% in 2022, then slumped by 289bps to 15.60% in 2023, then surged by 752bps to 23.12% in 2024, then soared by 294bps to 19.97% in 2025.
  • Its Tax Rate stands at 19.97% for Q3 2025, versus 19.42% for Q2 2025 and 17.89% for Q1 2025.